Search Results for keywords:"regulatory freeze"

The Centers for Medicare & Medicaid Services from the Department of Health and Human Services is delaying the effective date of a new rule concerning Medicare Part D. Originally set to take effect on February 1, 2021, the rule will now start on March 30, 2021. This delay follows a Presidential memorandum on January 20, 2021, aiming to freeze new regulations for 60 days. The rule in question will establish a new electronic standard for how prescribers and insurers manage authorizations for prescription drugs under Medicare Part D.

The Department of the Interior and the Department of the Army have decided to delay the effective date of a rule related to reservoir project lands. This decision is in line with a directive from President Trump's administration to pause new regulations for review. Initially set to take effect on April 16, 2025, the rule's implementation is postponed to May 16, 2025. The delay allows further evaluation and is made without public comments, as it aims to ensure regulations are carefully considered.

The Federal Motor Carrier Safety Administration (FMCSA) announced it will not enforce a rule titled "Federal Motor Carrier Safety Regulations; Correction" until March 20, 2025. This decision was made to allow time for a review of the rule by executive departments and agencies, ensuring it aligns with legal and policy requirements. The rule, originally published on January 10, 2025, corrected two errors in a previous regulation. FMCSA's action is part of a broader regulatory review initiated by the President.

The Food and Drug Administration (FDA) issued a rule regarding nonprescription drugs that require additional conditions for safe use. Originally set to take effect on January 27, 2025, the rule has been delayed twice and is now effective on May 27, 2025, due to a review process triggered by a presidential memorandum. The new rule establishes specific requirements for drug applications, labeling, and reporting related to these nonprescription drugs. The FDA intends to use this extra time for a thorough review, as immediate public input was deemed impractical and potentially against public interests, to ensure that entities affected by the rule have sufficient time to adjust their compliance strategies.

The Animal and Plant Health Inspection Service (APHIS), part of the U.S. Department of Agriculture (USDA), has announced a delay in the implementation of a set of record exemptions related to the Privacy Act. Originally set to be effective from January 10, 2025, these exemptions will now be postponed until April 11, 2025, following a regulatory freeze directive from the President. The records pertain to the Smuggling Interdiction and Trade Compliance National Information Communication Activity System (SNICAS), which tracks activities to prevent illegal importation of commodities. The delay allows APHIS to further review the exemptions, which restrict public access to certain law enforcement records.

The Agricultural Marketing Service of the USDA is delaying the start date of a rule originally set for December 30, 2024, which revises fees for import inspections of fresh fruits and vegetables. These changes included adjusting fees from a per-carlot to a per-pound basis and reducing fees for additional sublots. The delay, effective January 29, 2025, gives the department more time to review these regulations, following a directive from the President for a regulatory freeze pending further review. The delay is immediate and skips public comment because the rule's start date was approaching quickly.

On January 6, 2025, the U.S. Department of Housing and Urban Development (HUD) had planned to implement updates to the HOME Investment Partnerships Program on February 5, 2025. However, following a presidential directive for regulatory review, HUD initially delayed this to April 20, 2025. HUD now announces further delays for certain parts of the program: one key provision is delayed until October 30, 2025, while another is withdrawn, with other sections remaining scheduled for the original April date. These changes are meant to allow more time for public input and to ensure compliance with existing laws.

The memorandum from Ronald A. Klain, Assistant to the President, instructs executive departments and agencies to halt issuing new regulations until they are reviewed and approved by President Biden's appointees. It also suggests withdrawing rules sent to the Federal Register that haven't been published and postponing the effective dates for published rules not yet in effect for 60 days to allow for further review. Exceptions are allowed for urgent matters related to health, safety, or national security. The Office of Management and Budget (OMB) Director will oversee this process and handle any notifications regarding exclusions to the freeze.

The Office of Workers' Compensation Programs (OWCP) has decided to withdraw a notice and request for comments about self-insurance under the Black Lung Benefits Act that was initially published on January 8, 2021. This decision is due to changes in the legal rules and guidance that initially justified the publication. Although the notice has been withdrawn, there's no change to existing laws or regulations. OWCP plans to review the self-insurance bulletin and will allow the public to comment on self-insurance procedures at a future date.

The General Services Administration (GSA) is delaying the start of certain regulation changes, which were initially published on December 27, 2024, and planned to take effect in January 2025. This 60-day postponement ensures compliance with a Presidential Memorandum issued by President Donald J. Trump, which called for a regulatory freeze pending review. The regulation updates will now become effective on March 27, 2025.